1. Adams JU, Paronis CA, Holtzman SG (1990) Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine. J Pharmacol Exp Ther 255:1027–1032
2. Burke T, Woods JH, Lewis JW, Medzihradsky F (1994) Irreversible opioid anatagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice. J Pharmacol Exp Ther 271:715–721
3. Butelman ER, France CP, Woods JH (1995a) Agonist and antagonist effects of dynorphin A-(1–13) in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 275:374–380
4. Butelman ER, Negus SS, Gatch MB, Chang KJ, Woods JH (1995b) BW373U86, a ∂-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys. Eur J Pharmacol 277:285–287
5. Comer SD, Burke TF, Lewis JW, Woods JH (1992) Clocinnamox: a novel, systematically-active irreversible opioid antagonist. J Pharmacol Exp Ther 262:1051–1056